Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Dexmedetomidine for Delirium Prevention in Septic ICU Patients
NCT04876937Terminated
- Sponsor
- Peking University First Hospital
- Start
- May 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in delirium comparing Dexmedetomidine group with Placebo group (2 arms). Primary endpoint: Incidence of delirium within the first 7 days after enrollment. Started May 2021; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT04876937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04876937.